Skip main navigation

Definition of the role of OPAT in patient care

How do you define OPAT? What is its role and how does it fit into your organisation
Man with red question mark above his head
© BSAC

Outpatient parenteral antimicrobial therapy (OPAT) is the administration of at least 2 consecutive days of parenteral (usually intravenous) antimicrobial therapy without an overnight hospital stay. It is reserved for those patients with infection in whom parenteral antimicrobial therapy is required but who otherwise could be safely managed without hospital admission.

An OPAT service should be carefully designed and delivered to ensure safe and effective patient care. As such it is essential that a patient’s other social and healthcare needs can be managed safely in the home environment.

The aim of OPAT is to:

  1. Allow earlier hospital discharge for selected patients with deep seated infections requiring parenteral therapy e.g. osteomyelitis, endocarditis and device-related infections.
  2. Facilitate admission avoidance for selected patients with e.g. skin and soft tissue infections.

OPAT should not be used:

  1. In patients with infections where there is a suitable safe and effective oral antimicrobial agent.
  2. As an alternative to proper source control of the infection (e.g. instead of drainage of an abscess).
  3. In patients with unstable, rapidly progressive or unpredictable infections.

The main advantages of OPAT to the hospital or healthcare organisation are that length of stay is reduced or avoided all together so allowing more cost-efficient use of healthcare resources. Reducing hospital stay is also associated with reduction in risk from hospital related harm in general and hospital acquired infections in particular.

Antimicrobials used within OPAT are chosen for their specific characteristics which enable their safe and effective use in a non-inpatient setting (discussed in week 2). This means that sometimes antimicrobials are chosen which would not be routinely used in the inpatient setting and they may on occasion be more expensive. These higher “drug acquisition costs” are off set by the lower costs associated with overall outpatient care. How antimicrobial choice relates to the organisation’s wider antimicrobial stewardship programme is discussed further in week 2.

Please let us know in the comments below:

  • How much is OPAT used within your healthcare system?
  • How aware of OPAT were you before this course?
© BSAC
This article is from the free online

OPAT: Outpatient Parenteral Antimicrobial Therapy

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education